Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 10/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2125403 | 0.92 | MEN1 (0.38) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL7937643 | 0.90 | MEN1 (0.37) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL3788093 | 0.89 | CES2 (0.45) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL7782349 | 0.89 | CES2 (0.45) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL11839460 | 0.89 | CES2 (0.45) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL9246561 | 0.87 | CES2 (0.41) | MEN1KMT2ACES2 | |
| SCHEMBL7937641 | 0.87 | MEN1 (0.35) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL27569194 | 0.87 | MEN1 (0.35) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL2125404 | 0.85 | MEN1 (0.34) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL22117082 | 0.85 | CES2 (0.42) | MEN1MAPTKMT2AATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1917 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034046-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL | L'OREAL (FR) | 2026-02-05 | — | — | US | claimed |
| US-20260000602-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION | L'OREAL (FR) | 2026-01-01 | — | — | US | claimed |
| EP-4633743-A1 | KERATIN FIBRE TREATMENT PROCESS USING A PARTICULAR DIVALENT OR TRIVALENT FATTY ACID SALT AND COMPOSITION COMPRISING SAID SALT | L'OREAL (FR) | 2025-10-22 | — | — | EP | claimed |
| US-20250275895-A1 | ELECTROSTATICALLY SPRAYABLE TANNING FORMULATION | IONIQ SKINCARE GMBH & CO. KG (DE) | 2025-09-04 | — | — | US | claimed |
| EP-4609847-A1 | ELECTROSTATICALLY SPRAYABLE TANNING FORMULATION | IONIQ Skincare GmbH & Co. KG (DE) | 2025-09-03 | — | — | EP | claimed |
| WO-2025079114-A1 | A SELF-NANO EMULSIFYING DRUG FORMULATION FOR CHOLECALCIFEROL | VYTALS WELLBEING INDIA PVT. LTD. (IN) | 2025-04-17 | — | — | WO | claimed |
| CN-115551469-B | Hair care composition comprising a polyol, a C2-6 monohydric alcohol and a cationic surfactant | 莱雅公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119157760-A | Sun-proof spray for dull skin and preparation method thereof | 广东聚威健康产业有限公司 | 2024-12-20 | — | — | CN | claimed |
| EP-4470523-A1 | TOPICAL PHARMACEUTICAL COMPOSITIONS | Galenicum Health SLU (ES) | 2024-12-04 | — | — | EP | claimed |
| WO-2024191025-A1 | COSMETIC COMPOSITION COMPRISING CAPSULES OR BEADS | 한국콜마주식회사 | 2024-09-19 | — | — | WO | claimed |
| EP-2307463-A1 | OIL MIGRATION INHIBITED PRODUCT | Beiersdorf AG (DE) | 2011-04-13 | — | — | EP | claimed |
| WO-2010063155-A1 | PROCESS FOR PREPARING A STABLE HIGH OIL-PHASE CONTENT O/W EMULSION, THUS-PREPARED EMULSION AND USE THEREOF | EVONIK DEGUSSA (CHINA) CO., LTD (CN) | 2010-06-10 | — | — | WO | claimed |
| WO-2010009880-A1 | OIL MIGRATION INHIBITED PRODUCT | BEIERSDORF AG (DE) | 2010-01-28 | — | — | WO | claimed |
| US-20090292015-A1 | STABLE HIGH VITAMIN C CONTENT POLYOL-IN-OIL EMULSIFIED SYSTEM AND ITS PREPARATION | EVONIK GOLDSCHMIDT GMBH (DE) | 2009-11-26 | — | — | US | claimed |
| EP-2123257-A2 | Stable high Vitamin C content polyol-in-oil emulsified system and its preparation | Evonik Goldschmidt GmbH (DE) | 2009-11-25 | — | — | EP | claimed |
| WO-2009063158-A2 | PERSONAL CARE ARTICLE | RECKITT BENCKISER (UK) LIMITED (GB) | 2009-05-22 | — | — | WO | claimed |
| EP-2010128-A1 | PERSONAL CARE ARTICLE | Reckitt Benckiser Healthcare (UK) Limited (GB) | 2009-01-07 | — | — | EP | claimed |
| US-20080108709-A1 | COLD-PREPARABLE, LOW-VISCOSITY AND PROLONGED COSMETIC EMULSIONS WITH COEMULSIFIERS CONTAINING CATIONIC GROUPS | GOLDSCHMIDT GMBH (DE) | 2008-05-08 | — | — | US | claimed |
| WO-2007128983-A1 | PERSONAL CARE ARTICLE | RECKITT BENCKISER (UK) LIMITED (GB) | 2007-11-15 | — | — | WO | claimed |
| US-20070178144-A1 | Cold-preparable, low-viscosity and prolonged-stability cosmetic emulsions | GOLDSCHMIDT GMBH (DE) | 2007-08-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108709-A1 | COLD-PREPARABLE, LOW-VISCOSITY AND PROLONGED COSMETIC EMULSIONS WITH COEMULSIFIERS CONTAINING CATIONIC GROUPS | CUTA, PHOSPHO1, COL14A1 | MEN1 1091/4885MAPT 916/4885KMT2A 2210/4885 |
| US-20260000602-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION | TAS2R40, BRDT, APOB | MEN1 2028/4885MAPT 220/4885KMT2A 2378/4885 |
| US-20260034046-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL | KRT18, DSG1, PRKDC | MEN1 2343/4885MAPT 2819/4885KMT2A 1098/4885 |
| US-20090292015-A1 | STABLE HIGH VITAMIN C CONTENT POLYOL-IN-OIL EMULSIFIED SYSTEM AND ITS PREPARATION | PROC, TTPA, LIPC | MEN1 4105/4885MAPT 1124/4885KMT2A 4230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.